PROTEINFORMULIERUNGEN

European patent · EP2968460 · In force

Register entry

Publication number
EP2968460
Application number
EP14721569
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 7, 2014
Published
Jan 20, 2016
Granted
Jan 6, 2021
Protection ends at the latest
Mar 6, 2034
Next annual fee due
Mar 31, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 38/18 (2006.01)
A61K 9/19 (2006.01)
A61K 47/42 (2017.01)
A61K 47/26 (2006.01)
A61K 47/02 (2006.01)
C07K 16/22 (2006.01)
Priority
US 201361775974 P 11.03.2013
PCT application
PCT/US2014/021792 07.03.2014
PCT publication
WO2014/164301 09.10.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Nov 17, 2021

    Change

    Published in Swissreg on 17.11.2021

  6. Jan 6, 2021

    Granted

    Published in Swissreg on 06.01.2021

Parties

Holder

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventor

KUHNS, Scott

Newbury Park, California 91320, US

PHILLIPS, Joseph

Newbury Park, California 91320, US

PARK, Sungae

Thousand Oaks, California 91320, US

RATTAN, Jennifer

Thousand Oaks, California 91360, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.